Arbutus Biopharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ABUS and other ETFs, options, and stocks.

About ABUS

Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the development of imdusiran (AB-729), proprietary, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic, and AB-101, proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV). 

CEO
Lindsay Androski
CEOLindsay Androski
Employees
44
Employees44
Headquarters
Warminster, Pennsylvania
HeadquartersWarminster, Pennsylvania
Founded
2005
Founded2005
Employees
44
Employees44

ABUS Key Statistics

Market cap
631.88M
Market cap631.88M
Price-Earnings ratio
-8.85
Price-Earnings ratio-8.85
Dividend yield
—
Dividend yield—
Average volume
954.85K
Average volume954.85K
High today
$3.35
High today$3.35
Low today
$3.26
Low today$3.26
Open price
$3.31
Open price$3.31
Volume
529.04K
Volume529.04K
52 Week high
$4.73
52 Week high$4.73
52 Week low
$2.63
52 Week low$2.63
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.